Lebenthal, Y.; Brener, A.; Hershkovitz, E.; Shehadeh, N.; Shalitin, S.; Lewis, E.C.; Elias, D.; Haim, A.; Barash, G.; Loewenthal, N.;
et al. A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia®) in the Treatment of Recent-Onset Type 1 Diabetes. Int. J. Mol. Sci. 2019, 20, 6032.
https://doi.org/10.3390/ijms20236032
AMA Style
Lebenthal Y, Brener A, Hershkovitz E, Shehadeh N, Shalitin S, Lewis EC, Elias D, Haim A, Barash G, Loewenthal N,
et al. A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia®) in the Treatment of Recent-Onset Type 1 Diabetes. International Journal of Molecular Sciences. 2019; 20(23):6032.
https://doi.org/10.3390/ijms20236032
Chicago/Turabian Style
Lebenthal, Yael, Avivit Brener, Eli Hershkovitz, Naim Shehadeh, Shlomit Shalitin, Eli C. Lewis, Dana Elias, Alon Haim, Galia Barash, Neta Loewenthal,
and et al. 2019. "A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia®) in the Treatment of Recent-Onset Type 1 Diabetes" International Journal of Molecular Sciences 20, no. 23: 6032.
https://doi.org/10.3390/ijms20236032
APA Style
Lebenthal, Y., Brener, A., Hershkovitz, E., Shehadeh, N., Shalitin, S., Lewis, E. C., Elias, D., Haim, A., Barash, G., Loewenthal, N., Zuckerman-Levin, N., Stein, M., Tov, N., & Rachmiel, M.
(2019). A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia®) in the Treatment of Recent-Onset Type 1 Diabetes. International Journal of Molecular Sciences, 20(23), 6032.
https://doi.org/10.3390/ijms20236032
